INTERNATIONAL PATENT: MINDRANK AI LTD., 杭州德睿智药科技有限公司 FILES APPLICATION FOR "NOVEL FUSED HETEROCYCLIC COMPOUND SERVING AS CDK INHIBITOR AND USE THEREOF"

Posted On: 2025-03-03

GENEVA, March 3 -- MINDRANK AI LTD. (Unit 1901-1914, Bldg 2, 2 Kejiyuan Road, Baiyang Street, Qiantang District, Hangzhou, China (Zhejiang) Pilot Free Trade Zone,Hangzhou, Zhejiang 310018), 杭州德睿智药科技有限公司 (中国浙江省杭州市中国（浙江）自由贸易试验区杭州市钱塘区白杨街道科技园路2号2幢1901-1914室) filed a patent application (PCT/CN2024/114230) for "NOVEL FUSED HETEROCYCLIC COMPOUND SERVING AS CDK INHIBITOR AND USE THEREOF" on Aug 23, 2024. ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: MINDRANK AI LTD., 杭州德睿智药科技有限公司 FILES APPLICATION FOR "NOVEL FUSED HETEROCYCLIC COMPOUND SERVING AS CDK INHIBITOR AND USE THEREOF"